Postvaccine early-onset (PoVEO) forms of Graves' disease after anti-SARS-CoV-2 vaccination are characterized by favourable long-term disease outcomes.

di Filippo L, Acanfora M, Vassallo A, Valsecchi F, Castellino L, Rosen CJ, Giustina A

Open source

DOI
10.1007/s12020-025-04389-3
Published
2025 Nov
Container
Endocrine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s12020-025-04389-3,
  title = {Postvaccine early-onset (PoVEO) forms of Graves' disease after anti-SARS-CoV-2 vaccination are characterized by favourable long-term disease outcomes.},
  author = {di Filippo L and Acanfora M and Vassallo A and Valsecchi F and Castellino L and Rosen CJ and Giustina A},
  year = {2025},
  journal = {Endocrine},
  doi = {10.1007/s12020-025-04389-3},
  url = {https://doi.org/10.1007/s12020-025-04389-3}
}

RIS

TY  - JOUR
TI  - Postvaccine early-onset (PoVEO) forms of Graves' disease after anti-SARS-CoV-2 vaccination are characterized by favourable long-term disease outcomes.
AU  - di Filippo L
AU  - Acanfora M
AU  - Vassallo A
AU  - Valsecchi F
AU  - Castellino L
AU  - Rosen CJ
AU  - Giustina A
PY  - 2025
JO  - Endocrine
DO  - 10.1007/s12020-025-04389-3
UR  - https://doi.org/10.1007/s12020-025-04389-3
ER  - 

APA

L, D. F., M, A., A, V., F, V., L, C., CJ, R., & A, G. (2025). Postvaccine early-onset (PoVEO) forms of Graves' disease after anti-SARS-CoV-2 vaccination are characterized by favourable long-term disease outcomes.. Endocrine. https://doi.org/10.1007/s12020-025-04389-3

Source records